Molecular Targeting Technologies
West Chester, Pennsylvania, United States · Biotechnology, Health Care
Molecular Targeting Technologies, Inc. (MTTI) is a private, clinical-stage biotech company developing targeted radiopharmaceuticals (TRP) for rare cancers. MTTI is committed to building value by translating innovative TRP to improve human health.
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- West Chester, Pennsylvania, United States
- Employees
- 7
- Industries
- Biotechnology, Health Care
- Status
- Private
- Website
- www.mtarget.com
- Company page
Recent activity at Molecular Targeting Technologies
- : Molecular Targeting Technologies, Inc. has received a $3.17M grant from the National Cancer Institute to support the development of ¹⁷⁷Lu-EBRGD for non-small cell lung cancer.
- : Molecular Targeting Technologies, Inc. Appoints Dr. Danielle Meyrick as Chief Medical Officer
- : Molecular Targeting Technologies, Inc. announces the efficacy of 225Ac-EBTATE against neuroendocrine tumors based on preclinical study results.
About Molecular Targeting Technologies: questions and answers
What does Molecular Targeting Technologies do?
Molecular Targeting Technologies, Inc. (MTTI) is a private, clinical-stage biotech company developing targeted radiopharmaceuticals (TRP) for rare cancers. MTTI is committed to building value by translating innovative TRP to improve human health.
Where is Molecular Targeting Technologies headquartered?
Molecular Targeting Technologies is headquartered in West Chester, Pennsylvania, United States.
How many employees does Molecular Targeting Technologies have?
Molecular Targeting Technologies has about 7 employees.
What is the latest news on Molecular Targeting Technologies?
On Sep 23, 2026, Molecular Targeting Technologies, Inc. has received a $3.17M grant from the National Cancer Institute to support the development of ¹⁷⁷Lu-EBRGD for non-small cell lung cancer.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy